Dr. Robert Earl Wiggins Jr., MD

Dr. Wiggins practices at Asheville Eye Surgery Center (Medical Park Dr) in Asheville, North Carolina.

Dr. Wiggins' NPI, 1740261155, was assigned on November 11, 2005. Dr. Wiggins graduated from University of North Carolina at Chapel Hill School of Medicine in 1984. Dr. Wiggins holds North Carolina license 29448.

Dr. Wiggins' primary practice is Asheville Eye Surgery Center (Medical Park Dr), at 8b Medical Park Drive, Asheville, NC 28803. The practice phone is (828) 210-2020. Dr. Wiggins also practices at Asheville Eye Associates PLLC, 8 Medical Park Dr, Asheville, NC 28803.

Dr. Wiggins' primary practice is Asheville Eye Surgery Center (Medical Park Dr) in Asheville, North Carolina. Dr. Wiggins is also affiliated with Mission Hospital. Dmand AI also links Dr. Wiggins to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wiggins practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Wiggins' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Wiggins is licensed in North Carolina.

CMS data shows 6,305 Medicare services from Dr. Wiggins across 11 procedure codes in 2024, for 420 Medicare patients. Medicare paid $89,851 for them. Every service was in an office.

CMS counts 420 Medicare patients who saw Dr. Wiggins in 2024. The largest group is 65 to 74, with 163 patients. 70% of them have high cholesterol, and 66% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wiggins' median patient age at 67, with 63% women.

In 2024, Dr. Wiggins wrote 164 Medicare Part D claims for 52 patients. 79% of them were for generic drugs. CMS names the drug for 103 of them, across 3 drugs with 11 or more claims each, at $1,393 in total drug cost. In 2023, CMS named 123 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Wiggins for performance year 2024, reported through an alternative payment model (APM). Dr. Wiggins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Wiggins, published from 2015 to 2022. 2015 was the busiest year, with 2. The most frequent topics are Ophthalmology and Tomography, Optical Coherence. Dr. Wiggins' most frequent co-authors are Kent W. Small, MD, Steven A. Agemy, MD and Benjamin B.a. Bakall, MD, PhD.

CMS Open Payments shows 67 general payments to Dr. Wiggins from 18 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 62% of the total. Horizon Pharma plc paid the most, $3,366.

Dr. Wiggins graduated from University of North Carolina at Chapel Hill School of Medicine in 1984.